Timothy A Yap, MD
M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Timothy A Yap, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:29 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05039801 · IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsM.D. Anderson Cancer Center · recruiting · Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Malignant Solid Neoplasm · principal investigator
- Ph1NCT05010096 · BAY1895344 and Copanlisib for the Treatment of Molecularly Selected Patients With Advanced Solid TumorsM.D. Anderson Cancer Center · withdrawn · Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Solid Neoplasm · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:29 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- The effectiveness of a nurse-led home-based heart failure self-management programme (the HOM-HEMP) for patients with chronic heart failure: A three-arm stratified randomized controlled trial.Int J Nurs Stud · 202151 citationsRCR 4.7
- 50 citationsRCR 2.5
- Comparison of two techniques for assessing the shaping efficacy of repeatedly used nickel-titanium rotary instruments.J Endod · 201127 citationsRCR 1.6
- Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial.Lancet Oncol · 202524 citationsRCR 5.0